EXHIBIT 99.1
STANDBY EQUITY DISTRIBUTION AGREEMENT
THIS
STANDBY EQUITY DISTRIBUTION AGREEMENT (the "Agreement"),
dated as of
June 24, 2005, by and between CORNELL
CAPITAL PARTNERS,
LP, a Delaware
limited
partnership (the "Investor"), and NEXICON, INC., a corporation organized and
existing under the laws of the State of
Nevada (the "Company").
RECITALS:
WHEREAS,
the parties desire that, upon the terms and subject to the
conditions contained herein, the Company shall issue and sell
to the Investor,
from time to time as provided herein, and the Investor shall purchase
from the
Company up to Twenty Million Dollars ($20,000,000) of the Company's common
stock, par value $0.001 per share (the
"Common Stock"); and
WHEREAS,
such investments will
be made in reliance upon the provisions of
Regulation D ("Regulation D") of the
Securities Act of 1933, as amended, and the
regulations promulgated thereunder (the "Securities Act"), and or upon such
other exemption from the registration
requirements of the
Securities Act as may
be available with respect to any or all of
the investments to be made hereunder.
WHEREAS,
the Company has
engaged Newbridge Securities Inc., to act as the
Company's exclusive placement agent in
connection with the sale of the Company's
Common Stock to the Investor hereunder
pursuant to the Placement Agent Agreement
dated the date hereof by and among the
Company, the Placement Agent and the
Investor (the "Placement Agent
Agreement").
NOW,
THEREFORE, the parties hereto agree as follows:
ARTICLE I.
CERTAIN DEFINITIONS
Section
1.1. "Advance"
shall mean the portion
of the Commitment
Amount
requested by the Company in the Advance
Notice.
Section
1.2. "Advance Date" shall mean the date David
Gonzalez, Esq.
Escrow Account is in receipt of the funds
from the Investor and David Gonzalez,
Esq., as the Investor's Counsel, is in possession of free trading
shares from
the Company and therefore an Advance by the
Investor to the Company can be made
and David Gonzalez, Esq. can release the
free trading shares to the Investor. No
Advance Date shall be less than six (6)
Trading Days after an Advance Notice
Date.
Section
1.3. "Advance Notice"
shall mean a written notice to the Investor
setting forth the Advance amount that the
Company requests from the Investor and
the Advance Date.
<PAGE>
Section
1.4. "Advance Notice Date" shall mean each date the Company
delivers to the Investor an Advance Notice requiring the Investor to advance
funds to the Company, subject to the terms of this
Agreement. No Advance Notice
Date shall be less than six (6)
Trading Days after the prior Advance Notice
Date.
Section
1.5. "Bid Price" shall
mean, on any date,
the closing bid
price
(as reported by Bloomberg L.P.) of the Common Stock on the
Principal Market
or
if the Common Stock is not traded on a
Principal Market,
the highest
reported
bid price for the Common Stock, as furnished by the National Association of
Securities Dealers, Inc.
Section
1.6. "Closing" shall mean one of the closings of
a purchase and
sale of Common Stock pursuant to Section
2.3.
Section
1.7. "Commitment
Amount" shall mean the aggregate amount of up to
Twenty Million Dollars ($20,000,000) which
the Investor has agreed to provide to
the Company in order to purchase
the Company's Common Stock pursuant to the
terms and conditions of this Agreement.
Section
1.8. "Commitment
Period" shall mean the
period commencing on the
earlier to occur of (i) the Effective Date, or (ii) such earlier date as the
Company and the Investor may mutually agree in writing, and expiring on the
earliest to occur of (x) the date on which
the Investor shall
have made payment
of Advances pursuant to this Agreement in
the aggregate amount of Twenty Million
Dollars ($20,000,000) , (y) the date this Agreement is
terminated pursuant
to
Section 2.5, or (z) the date occurring twenty-four (24) months after the
Effective Date.
Section
1.9. "Common
Stock" shall mean the
Company's common
stock, par
value $0.001 per share.
Section
1.10. "Condition Satisfaction Date" shall have the meaning
set
forth in Section 7.2.
Section
1.11. "Damages" shall
mean any loss, claim,
damage, liability,
costs and expenses (including, without limitation, reasonable attorney's fees
and disbursements and costs and expenses of
expert witnesses and investigation).
Section
1.12. "Effective Date"
shall mean the date on which the SEC first
declares effective a Registration Statement registering the resale of the
Registrable Securities as set forth in
Section 7.2(a).
Section
1.13. "Escrow Agreement" shall mean the escrow agreement among
the
Company, the Investor, and David Gonzalez,
Esq. dated the date hereof.
Section
1.14. "Exchange
Act" shall mean the
Securities
Exchange Act of
1934, as amended, and the rules and
regulations promulgated thereunder.
Section
1.15. "Material Adverse Effect" shall mean any condition,
circumstance, or situation that would
prohibit or otherwise materially interfere
with the ability of the Company to enter
into and perform any of its obligations
under this Agreement or the Registration Rights Agreement in any material
respect.
2
<PAGE>
Section
1.16. "Market
Price" shall mean the
lowest VWAP of the Company's
Common Stock during the Pricing Period.
Section
1.17. "Maximum
Advance Amount" shall be Three Hundred
Thousand
Dollars ($300,000) per Advance Notice.
Section
1.18 "NASD"
shall mean the
National Association
of Securities
Dealers, Inc.
Section
1.19 "Person" shall mean an individual, a corporation, a
partnership, an association, a trust or
other entity or organization, including
a government or political subdivision or an
agency or instrumentality thereof.
Section
1.20 "Placement
Agent" shall mean
Newbridge Securities
Inc., a
registered broker-dealer.
Section
1.21 "Pricing Period" shall mean the five (5) consecutive
Trading
Days after the Advance Notice Date.
Section
1.22 "Principal Market" shall mean the Nasdaq National Market,
the
Nasdaq SmallCap Market, the American Stock Exchange,
the OTC Bulletin Board
or
the New York Stock Exchange, whichever is at the time the principal trading
exchange or market for the Common
Stock.
Section
1.23 "Purchase Price" shall be set at ninety nine percent (99%)
of
the Market Price during the Pricing
Period.
Section
1.24 "Registrable Securities" shall mean the shares of Common
Stock to be issued hereunder (i) in respect
of which the Registration Statement
has not been declared effective by the SEC, (ii) which
have not been sold under
circumstances meeting all of the applicable conditions of Rule 144 (or any
similar provision then in force) under the
Securities Act ("Rule 144") or (iii)
which have not been otherwise transferred to a holder who may
trade such shares
without restriction under the Securities Act, and the Company has delivered
a
new certificate or other evidence of
ownership for such securities not bearing a
restrictive legend.
Section
1.25 "Registration
Rights Agreement"
shall mean the Registration
Rights Agreement dated the date hereof,
regarding the filing of the Registration
Statement for the resale of the Registrable
Securities, entered into between the
Company and the Investor.
Section
1.26 "Registration
Statement" shall mean a registration statement
on Form S-1 or SB-2 (if use of such form is then available to the Company
pursuant to the rules of the SEC and, if
not, on such other form promulgated by
the SEC for which the Company then
qualifies and which counsel for the
Company
shall deem appropriate, and which form shall be available
for the resale of the
Registrable Securities to be registered there under in accordance with the
provisions of this Agreement and the Registration Rights Agreement, and in
accordance with the intended method of
distribution of such securities), for the
registration of the resale by the Investor
of the Registrable
Securities under
the Securities Act.
3
<PAGE>
Section
1.27 "Regulation D" shall have the meaning set forth in the
recitals of this Agreement.
Section
1.28 "SEC" shall mean the Securities and Exchange Commission.
Section
1.29 "Securities Act" shall have the meaning set forth in the
recitals of this Agreement.
Section
1.30 "SEC Documents" shall mean Annual Reports on Form 10-KSB,
Quarterly Reports on Form 10-QSB, Current Reports on Form 8-K and Proxy
Statements of the Company as supplemented to the date hereof, filed by the
Company for a period of at least twelve
(12) months
immediately preceding
the
date hereof or the Advance Date, as the case may be, until such time as the
Company no longer has an obligation to maintain the effectiveness of a
Registration Statement as set forth in the
Registration Rights Agreement.
Section
1.31 "Trading Day" shall mean any day during
which the New York
Stock Exchange shall be open for
business.
Section
1.32 "VWAP" shall mean the volume weighted average price of the
Company's Common Stock as quoted by
Bloomberg, LP.
ARTICLE II.
ADVANCES
Section
2.1. Investments.
(a) Advances.
Upon the terms and conditions set forth herein
(including, without limitation, the provisions of Article VII
hereof), on any
Advance Notice Date the Company may request an Advance by
the Investor by
the
delivery of an Advance Notice. The number of shares of Common
Stock that the
Investor shall receive for each Advance
shall be determined by dividing the
amount of the Advance by the Purchase Price. No fractional shares shall be
issued. Fractional shares shall be rounded to the next
higher whole number of
shares. The aggregate maximum amount of
all Advances that the Investor shall be
obligated to make under this Agreement
shall not exceed the Commitment Amount.
Section
2.2. Mechanics.
(a) Advance Notice. At
any time during the Commitment Period, the
Company may deliver an Advance Notice to
the Investor, subject to the conditions
set forth in Section 7.2; provided, however, the amount for each Advance as
designated by the Company in the applicable
Advance Notice, shall not be more
than the Maximum Advance Amount.
The aggregate amount
of the Advances
pursuant
to this Agreement shall not exceed the Commitment Amount. The Company
acknowledges that the Investor may sell shares of the
Company's Common Stock
corresponding with a particular Advance Notice
on the day the Advance Notice is
received by the Investor. There will be a
minimum of six(6) Trading Days between
each Advance Notice Date.
4
<PAGE>
(b) Date of Delivery of Advance Notice. An Advance Notice shall be
deemed delivered on (i) the Trading Day it
is received by facsimile or otherwise
by the Investor if such notice is received
prior to 12:00 noon
Eastern Time, or
(ii) the immediately succeeding Trading Day if it is received by
facsimile or
otherwise after 12:00 noon Eastern Time on
a Trading Day or at any time on a day
which is not a Trading Day. No Advance
Notice may be deemed delivered, on a day
that is not a Trading Day.
Section
2.3. Closings. On each Advance Date, which shall be six (6)
Trading Days after an Advance Notice Date, (i) the Company shall
deliver to the
Investor's Counsel, as defined pursuant to the Escrow
Agreement, shares of
the
Company's Common Stock, representing the amount of the
Advance by the Investor
pursuant to Section 2.1 herein,
registered
in the name of the
Investor which
shall be delivered to the Investor,
or otherwise in
accordance with the
Escrow
Agreement and (ii) the Investor shall deliver to David Gonzalez, Esq. (the
"Escrow Agent") the amount of the Advance
specified in the Advance Notice by
wire transfer of immediately available funds which shall be delivered to
the
Company, or otherwise in accordance with
the Escrow Agreement.
In addition, on
or prior to the Advance Date, each of the
Company and the Investor shall deliver
to the other through the Investor's Counsel all documents, instruments and
writings required to be delivered by either
of them pursuant to this Agreement
in order to implement and effect the
transactions
contemplated herein.
Payment
of funds to the Company and delivery of the Company's Common Stock to the
Investor shall occur in accordance with the
conditions set forth above and those
contained in the Escrow Agreement; provided, however, that to the extent the
Company has not paid the fees, expenses, and disbursements of the Investor
and
the Investor's counsel in accordance with
Section 12.4, the amount of such fees,
expenses, and disbursements may be deducted by
the Investor (and shall be paid
to the relevant party) from the amount of the
Advance with no reduction in the
amount of shares of the Company's Common Stock to be delivered on
such Advance
Date. Section 2.4. Termination of
Investment. The
obligation of the Investor to
make an Advance to the Company pursuant to this Agreement shall terminate
permanently (including with respect to an Advance Date that has not yet
occurred) in the event that (i) there shall
occur any stop order or suspension
of the effectiveness of the Registration Statement for an aggregate of
fifty
(50) Trading Days, other than due to the acts of the
Investor, during the
Commitment Period, and (ii) the Company shall at any time fail
materially to
comply with the requirements of Article VI and
such failure is not cured within
thirty (30) days after receipt of written
notice from the
Investor, provided,
however, that this termination provision shall not apply to any period
commencing upon the filing of a
post-effective
amendment to such
Registration
Statement and ending upon the date on which
such post effective
amendment is
declared effective by the SEC..
Section
2.5. Agreement to Advance Funds.
(a) The Investor
agrees to advance the amount specified in the
Advance Notice to the Company after the completion of each of the following
conditions and the other conditions set
forth in this Agreement:
5
<PAGE>
(i) the execution and delivery by the Company, and the
Investor, of this Agreement, and the
Exhibits hereto;
(ii) Investor's
Counsel shall have received the shares of
Common Stock applicable to the Advance in
accordance with Section 2.2(c) hereof;
(iii) the Company's Registration Statement with respect to the
resale of the Registrable Securities in accordance with the terms of the
Registration Rights Agreement shall have
been declared effective by the SEC;
(iv) the
Company shall have obtained all material permits and
qualifications required by any applicable state for the offer and sale of
the
Registrable Securities, or shall have the availability of
exemptions therefrom.
The sale and issuance of the Registrable
Securities shall be
legally permitted
by all laws and regulations to which the
Company is subject;
(v) the Company
shall have filed
with the Commission in a
timely manner all reports, notices and other documents
required of a "reporting
company" under the Exchange Act and
applicable Commission regulations;
(vi) the fees as set forth in Section 12.4 below shall have
been paid or can be withheld as provided in
Section 2.3; and
(vii) the conditions
set forth in Section 7.2 shall have been
satisfied.
(viii) The Company
shall have
provided to the Investor an
acknowledgement, from Stark Winter Schenkein & Co., LLP as to its ability to
provide all consents required in order to file a registration statement in
connection with this transaction;
(ix) The Company's transfer agent shall be DWAC eligible.
Section
2.6. Lock Up Period.
(i) During the Commitment Period, the Company shall not, issue
or sell (i) any Common Stock or Preferred
Stock without
consideration or for
a
consideration per share less than the Bid Price
on the date of issuance or (ii)
issue or sell any warrant, option, right, contract,
call, or other
security or
instrument granting the holder thereof the
right to acquire Common Stock without
consideration or for a consideration per share less than the Bid Price
on the
date of issuance.
(ii) On the date
hereof, the Company
shall obtain from
each
officer and director a lock-up agreement,
as defined below, in
the form annexed
hereto as Schedule 2.6 agreeing to only sell in compliance with the volume
limitation of Rule 144.
ARTICLE III.
REPRESENTATIONS AND WARRANTIES OF INVESTOR
Investor
hereby represents and warrants to, and
agrees with, the Company
that the following are true and as of the date
hereof and as of each
Advance
Date:
6
<PAGE>
Section
3.1. Organization and Authorization. The Investor is duly
incorporated or organized and validly existing in the jurisdiction of its
incorporation or organization and has all requisite power and authority to
purchase and hold the securities issuable
hereunder. The
decision to invest and
the execution and delivery of this
Agreement by such Investor, the performance
by such Investor of its obligations hereunder and the consummation by such
Investor of the transactions contemplated hereby have been duly authorized
and
requires no other proceedings on the part of the
Investor. The
undersigned has
the right, power and authority to execute and deliver
this Agreement
and all
other instruments (including, without limitations, the Registration Rights
Agreement), on behalf of the Investor. This
Agreement has been duly executed and
delivered by the Investor and, assuming the execution and delivery
hereof and
acceptance thereof by the Company,
will constitute the
legal, valid and binding
obligations of the Investor, enforceable
against the Investor in accordance with
its terms.
Section
3.2. Evaluation
of Risks. The Investor has such knowledge and
experience in financial tax and business
matters as to be
capable of evaluating
the merits and risks of, and bearing the economic risks entailed by, an
investment in the Company and of protecting
its interests in connection
with
this transaction. It recognizes that its investment
in the Company
involves a
high degree of risk.
Section
3.3. No Legal Advice From the Company. The Investor acknowledges
that it had the opportunity to review this Agreement and the transactions
contemplated by this Agreement with his or its
own legal counsel and investment
and tax advisors. The Investor is relying
solely on such counsel
and advisors
and not on any statements or representations of the Company or any of its
representatives or agents for legal, tax or investment advice with respect to
this investment, the transactions contemplated by this Agreement or the
securities laws of any jurisdiction.
Section
3.4. Investment Purpose. The securities are being purchased by
the
Investor for its own account, for investment and without any view to the
distribution, assignment or resale to
others or fractionalization in whole or in
part. The Investor agrees not to assign or in any way
transfer the
Investor's
rights to the securities or any interest therein and acknowledges that the
Company will not recognize any purported assignment or transfer except in
accordance with applicable Federal and state securities laws. No other person
has or will have a direct or indirect
beneficial interest in the securities. The
Investor agrees not to sell, hypothecate or otherwise
transfer the
Investor's
securities unless the securities are registered under Federal and applicable
state securities laws or unless,
in the opinion of
counsel satisfactory
to the
Company, an exemption from such laws is
available.
Section
3.5. Accredited Investor. The Investor is an "Accredited
Investor"
as that term is defined in Rule 501(a)(3)
of Regulation D of the Securities Act.
Section
3.6. Information. The Investor and its advisors (and its
counsel),
if any, have been furnished with all materials relating to the business,
finances and operations of the Company and
information
it deemed material to
making an informed investment decision.
The Investor and its
advisors, if any,
have been afforded the opportunity to ask questions of the Company and its
management. Neither such inquiries nor any other due
diligence
investigations
conducted by such Investor or its advisors,
if any, or its representatives shall
modify, amend or affect the Investor's right to rely on the Company's
7
<PAGE>
representations and warranties contained in this Agreement. The Investor
understands that its investment
involves a high degree
of risk. The Investor is
in a position regarding the Company, which, based upon employment, family
relationship or economic bargaining power,
enabled and enables
such Investor to
obtain information from the Company in
order to evaluate the merits and risks of
this investment. The Investor has sought
such accounting, legal
and tax advice,
as it has considered necessary to make an informed
investment
decision with
respect to this transaction.
Section
3.7. Receipt of Documents. The Investor and its counsel has
received and read in their entirety: (i)
this Agreement and the Exhibits annexed
hereto; (ii) all due diligence and other information necessary to verify the
accuracy and completeness of such representations, warranties and covenants;
(iii) the Company's Form 10-KSB for the year ended
year ended December 31, 2004
and Form 10-QSB for the period ended March 31, 2005; and (iv) answers to all
questions the Investor submitted to the Company
regarding an
investment in the
Company; and the Investor has relied on the
information contained
therein and
has not been furnished any other documents, literature, memorandum or
prospectus.
Section
3.8. Registration
Rights Agreement and Escrow Agreement. The
parties have entered into the Registration Rights Agreement and the Escrow
Agreement, each dated the date hereof.
Section
3.9. No General Solicitation. Neither the Company, nor any of
its
affiliates, nor any person acting on its or their
behalf, has engaged in any
form of general solicitation or general advertising (within the meaning of
Regulation D under the Securities
Act) in connection
with the offer or sale
of
the shares of Common Stock offered
hereby.
Section
3.10. Not an Affiliate. The Investor is not an officer,
director
or a person that directly, or indirectly through one or more intermediaries,
controls or is controlled by, or is under
common control with the Company or any
"Affiliate" of the Company (as that term is defined in Rule 405 of the
Securities Act). Neither the Investor nor its Affiliates has an open short
position in the Common Stock of the Company, and the Investor agrees that it
will not, and that it will cause its Affiliates not to, engage in any short
sales of or hedging transactions with
respect to the Common Stock, provided that
the Company acknowledges and agrees that upon receipt of an
Advance Notice the
Investor will sell the Shares to be issued to the Investor pursuant to the
Advance Notice, even if the Shares have not
been delivered to the Investor.
Section
3.11. Trading
Activities. The
Investor's trading activities with
respect to the Company's Common Stock shall
be in compliance with all applicable
federal and state securities laws, rules and regulations and the rules and
regulations of the Principal Market on which the Company's Common Stock is
listed or traded. Neither the Investor nor its affiliates has an open short
position in the Common Stock of the Company
and, except as set forth below, the
Investor shall not and will cause its
affiliates not to engage in any short sale
as defined in any applicable SEC or
National Association
of Securities
Dealers
rules on any hedging transactions with respect to the Common Stock. Without
limiting the foregoing, the Investor agrees not to engage in any naked
short
transactions in excess of the amount of shares owned (or an offsetting long
position) during the Commitment
Period. The Investor shall be entitled to
sell
Common Stock during the applicable Pricing
Period.
8
<PAGE>
ARTICLE IV.
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
Except as
stated below, on the disclosure schedules attached hereto or
in
the SEC Documents (as defined herein), the Company hereby represents and
warrants to, and covenants with, the Investor that the following
are true and
correct as of the date hereof:
Section
4.1. Organization and Qualification. The Company is duly
incorporated or organized and validly existing in the jurisdiction of its
incorporation or organization and has all requisite power and authority
corporate power to own its properties and to
carry on its business as now being
conducted. Each of the Company and its subsidiaries is duly qualified as a
foreign corporation to do business and is
in good standing in every jurisdiction
in which the nature of the business conducted by it makes such qualification
necessary, except to the extent that the failure to be so
qualified or be in
good standing would not have a Material
Adverse Effect on the Company and its
subsidiaries taken as a whole.
Section
4.2.
Authorization,
Enforcement,
Compliance
with
Other
Instruments. (i) The Company has the requisite
corporate power and authority to
enter into and perform this Agreement,
the Registration
Rights Agreement,
the
Escrow Agreement, the Placement Agent Agreement and
any related agreements, in
accordance with the terms hereof and
thereof, (ii) the execution and delivery of
this Agreement, the Registration Rights Agreement, the Escrow Agreement, the
Placement Agent Agreement and any related agreements by the Company and the
consummation by it of the transactions contemplated hereby and thereby, have
been duly authorized by the Company's Board
of Directors and no further consent
or authorization is required by the Company, its Board of Directors or its
stockholders, (iii) this Agreement, the Registration Rights Agreement, the
Escrow Agreement, the Placement Agent Agreement and
any related agreements have
been duly executed and delivered by the Company, (iv) this Agreement, the
Registration Rights Agreement, the Escrow Agreement, the Placement Agent
Agreement and assuming the execution and
delivery thereof and
acceptance by the
Investor and any related agreements
constitute the valid and binding obligations
of the Company enforceable against the Company in accordance
with their terms,
except as such enforceability may be limited by
general principles of equity or
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting
generally, the
enforcement of creditors'
rights and remedies.
Section
4.3. Capitalization. As of the date hereof, the authorized
capital
stock of the Company consists of 500,000,000
shares of Common
Stock, par value
$0.001 per share and no shares of Preferred
Stock of which 153,096,425 shares of
Common Stock and no shares of Preferred
Stock were issued and
outstanding. All
of such outstanding shares have been validly issued and are fully paid and
nonassessable. Except as disclosed in the SEC Documents, no shares of Common
Stock are subject to preemptive
rights or any other
similar rights or any liens
or encumbrances suffered or permitted by
the Company. Except as disclosed in the
SEC Documents, as of the date hereof,
(i) there are no
outstanding
options,
warrants, scrip, rights to subscribe to, calls or
commitments of any character
whatsoever relating to, or securities or
rights convertible into, any shares of
capital stock of the Company or any of its subsidiaries, or contracts,
commitments, understandings or arrangements by which the
Company or any of its
subsidiaries is or may become bound to
issue additional
shares of capital stock
of the Company or any of its subsidiaries
or options, warrants, scrip, rights to
9
<PAGE>
subscribe to, calls or commitments of any
character whatsoever
relating to, or
securities or rights convertible into, any shares of capital stock of the
Company or any of its subsidiaries, (ii) there are no outstanding debt
securities (iii) there are no outstanding
registration
statements other than on
Form S-8 and (iv) there are no agreements or arrangements under which the
Company or any of its subsidiaries is obligated to register the sale
of any of
their securities under the Securities Act (except
pursuant to the Registration
Rights Agreement). There are no securities or instruments containing
anti-dilution or similar provisions that will be triggered
by this Agreement or
any related agreement or the consummation of
the transactions
described herein
or therein. The Company has furnished to
the Investor true and correct copies of
the Company's Certificate of Incorporation,
as amended and as in
effect on the
date hereof (the "Certificate of
Incorporation"), and
the Company's By-laws, as
in effect on the date hereof (the
"By-laws"),
and the terms of all
securities
convertible into or exercisable for Common
Stock and the material rights of the
holders thereof in respect thereto.
Section
4.4. No Conflict. The execution, delivery and performance of
this
Agreement by the Company and the
consummation by the Company of the transactions
contemplated hereby will not (i) result in a
violation of the
Certificate
of
Incorporation, any certificate of designations of any outstanding series of
preferred stock of the Company or By-laws or
(ii) conflict with or constitute a
default (or an event which with notice or lapse of time
or both would become
a
default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any
agreement, indenture or instrument to which
the Company or any of its subsidiaries is a party, or result in a
violation of
any law, rule, regulation, order, judgment or decree (including federal and
state securities laws and regulations and the rules and regulations of the
Principal Market on which the Common Stock
is quoted) applicable
to the Company
or any of its subsidiaries or by which any material property or asset of the
Company or any of its subsidiaries is bound or affected
and which would cause a
Material Adverse Effect. Except as disclosed in the SEC
Documents, neither
the
Company nor its subsidiaries is in violation of
any term of or in default under
its Certificate of Incorporation or By-laws
or their
organizational charter
or
by-laws, respectively, or any material contract, agreement, mortgage,
indebtedness, indenture, instrument, judgment, decree or
order or any statute,
rule or regulation applicable to the Company or its
subsidiaries. The
business
of the Company and its subsidiaries is not being conducted in
violation of any
mat